Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket

Shares of Dayforce Inc (NYSE:DAY) rose sharply in pre-market trading.

Benzinga

Novo Nordisk's Wegovy Snags Conditional FDA Nod For Fatty Liver Disease

On Saturday, the U.S. Food and Drug Administration (FDA) approved an additional indication for Novo Nordisk A/S’ (NYSE:NVO) Wegovy (semaglutide 2.4 mg) based on a supplemental New Drug Application (sNDA) for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3…

Benzinga

Ozempic Lawsuit: Patients Claim Life-Threatening Side Effects As Safety Questions Put Zepbound In The Spotlight

Over 2,000 Ozempic and Zepbound lawsuits allege life-threatening side effects as FDA updates warnings and courts weigh evidence.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Florida Mum Suffers Miscarriage After Raw Milk 'Poisoning' – But Why Are So Many Still Drinking It?

A Florida mother claims raw milk caused her miscarriage amid outbreak tied to Keely Farms Dairy. Officials warn of risks for pregnant women and children.

International Business Times UK

Ultrahuman's smart ring adds "medical-grade" cycle tracking – for a price

The new Cycle & Ovulation Pro plug-in brings FDA-cleared fertility tech to the Ultrahuman Ring AIR

It's About to Get a Lot Harder To Buy Your Favorite K-Beauty Products

Government regulations are coming for your Korean sheet masks and SPF.

Marie Claire

Why Is Precigen Stock Surging On Friday?

On Friday, the U.S. Food and Drug Administration (FDA) approved Precigen Inc.’s (NASDAQ:PGEN) Papzimeos (zopapogene imadenovec-drba) for adult patients with recurrent respiratory papillomatosis (RRP).

Benzinga

Read news from The Economist, FT, and more,
with one subscription

The growing fad of ‘microdosing’ mushrooms is leading to an uptick in poison control center calls and emergency room visits

Imagine you purchase a bag of gummies labeled nootropic – a term used to describe substances that claim to enhance mental ability and function, or “smart drugs.” However, within hours of consuming them, your heart starts racing, you’re nauseated and vomiting. Then you begin convulsing and have a seizure, resulting…

The Conversation

Whoop refuses to back down after FDA calls blood pressure feature a medical device

The battle over blood pressure tracking could reshape what wearables can legally do (in the US)

FDA warns lead could be leaching into food from this cookware

Lead is toxic to people of any age or health status and higher exposure levels can lead to neurological changes

The Independent UK

Faith-based activist groups celebrate after Costco bails on selling abortion pill

‘They have nothing to gain and much to lose by becoming abortion dispensaries,’ Alliance Defending Freedom Legal Counsel Michael Ross said

The Independent UK

What's Going On With Tonix Pharmaceuticals (TNXP) Stock?

Shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) have rallied 30% over the past five sessions, though are marginally lower Thursday afternoon, as investors anticipate a key catalyst for the company.

Benzinga

7 Products Pulled for Undisclosed Ingredients

When a food company recalls a product, it is often because of a serious and potentially life-threatening mistake: the presence of an undisclosed ingredient. This usually happens when a major allergen, like nuts or dairy, is accidentally introduced into a product that is not supposed to contain it. For people…

Grocery Coupon Guide

Whoop stands firm against FDA pressure over Blood Pressure insights tool

Whoop and the FDA clashed in recent issues over the former's BPI tool on its MG fitness band.

Android Central

Get all your
news in one place.

100's of premium titles.
One news app.

Grocery Coupon Guide

8 Snack Labels That Mislead About Health Benefits

Walk down any grocery store snack aisle, and you’ll find products proudly displaying labels like “natural,” “low-fat,” or “made with real fruit.” These claims sound reassuring, but they don’t always tell the full story. In reality, some so-called healthy snacks are packed with sugar, sodium, or artificial additives that can…

The Independent UK

Laura Loomer sets her sights on her next target to get the boot from the Trump administration

‘I’m not naive enough to think that the president is going to get rid of RFK, but I will say that … there are concerns about some of the staffing decisions over at HHS,’ Laura Loomer said this week.

The Conversation

COVID-19 vaccines for kids are mired in uncertainty amid conflicting federal guidance

It’s August, and parents and caregivers are frantically preparing their kids for a new school year by buying supplies, filling out forms and meeting teachers. This year, many parents also face a question that’s more complicated than usual: Should my child get an updated COVID-19 vaccine, and will I even…

Benzinga

Cognition Therapeutics Surges 30% Pre-Market After FDA Backs Phase 3 Trial Design For Alzheimer's Drug

Cognition Therapeutics Inc. (NASDAQ:CGTX) shares jumped 30% to $1.43 in pre-market trading on Wednesday after the company announced FDA confirmation of its Phase 3 trial design for Alzheimer’s drug Zervimesine (CT1812).

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside

Per two Wall Street analysts, one of 2025's biggest losers could be set up for a stunning recovery. They see over 175% upside in Sarepta Therapeutics.

Benzinga

Why Is Liquidia Stock Trading Higher On Tuesday?

Liquidia Corporation (NASDAQ:LQDA) reported on Tuesday a second-quarter loss of 49 cents, missing the consensus of a loss of 43 cents.

Benzinga

FDA Approves Insmed's Drug As First Treatment For Type Of Chronic Lung Disease

The U.S. Food and Drug Administration (FDA) on Tuesday approved Insmed Incorporated’s (NASDAQ:INSM) Brinsupri (brensocatib 10 mg and 25 mg tablets). It is an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and children 12 years and older.

Benzinga

CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency

A group of former U.S. Centers for Disease Control and Prevention (CDC) employees are blaming HHS Secretary Robert F. Kennedy Jr. for vilifying the agency’s workforce through “his continuous lies about science and vaccine safety, which have fueled a climate of hostility and mistrust."

Benzinga

Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum

On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated New Drug Application (ANDA) for Iron Sucrose Injection, USP 50mg/2.5mL, 100mg/5mL, and 200mg/10mL in single-dose vials, previously referred to as AMP-002.

Benzinga

Hims & Hers Remains Outside Novo Nordisk's Growing Legal Storm For Now

Hims Hers Health Inc. (NYSE:HIMS) has been one of 2025’s hottest telehealth stocks, nearly doubling in value year to date, but a deepening clash with Novo Nordisk A/S (NYSE:NVO) over compounded weight-loss drugs, and shifting FDA rules, has turned momentum into headwinds, sending shares sliding 10% in the past three…

Grocery Coupon Guide

7 Times Pet Food Was Recalled Without National Coverage

When a major pet food recall happens, it often makes national news, sending worried pet owners rushing to check their pantries. However, many smaller recalls issued by the U.S. Food and Drug Administration (FDA) never make the headlines. These quiet recalls can involve products contaminated with dangerous bacteria like Salmonella…

1 … 31 32 33 34

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Health and Human Services

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.